[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340078-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-340078-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","lipid-peroxidation-regulators-gpx4-and-fsp1-as-prognostic-markers-and-therapeutic-targets-in-advanced-gastric-cancer-article-summary","Lipid Peroxidation Regulators GPX4 and FSP1 as Prognostic Markers and Therapeutic Targets in Advanced Gastric Cancer - Article Summary","","Gastric cancer remains one of the most common cancers worldwide, with a continuing need for effective therapies. The study focuses on ferroptosis, an intracellular iron-dependent cell death driven by lipid peroxidation, distinct from apoptosis and necrosis. Using patient tissues, immunohistochemistry assessed GPX4, FSP1, and 4-HNE to link expression and lipid peroxidation with prognosis. In vitro inhibition of GPX4 and FSP1 showed synergistic, non-apoptotic cell death. Results suggest targeting GPX4 and FSP1 could benefit patients with poor prognosis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/lipid-peroxidation-regulators-gpx4-and-fsp1-as-prognostic-markers-and-therapeutic-targets-in-advanced-gastric-cancer-article-summary/340078/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/lipid-peroxidation-regulators-gpx4-and-fsp1-as-prognostic-markers-and-therapeutic-targets-in-advanced-gastric-cancer-article-summary/340078.png","ImageObject",300,407,{"name":42,"@type":43},"Miles","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What biological process is emphasized as a new therapeutic strategy in advanced gastric cancer?","Question",{"text":63,"@type":64},"The article emphasizes ferroptosis, an intracellular iron-dependent cell death caused by accumulation of lipid peroxidation. This process differs from apoptosis and necrosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which biomarkers are evaluated to assess prognosis in gastric cancer patients?",{"text":68,"@type":64},"The study evaluates GPX4, FSP1, and 4-HNE in patient tissues using immunohistochemistry. Their expression levels and 4-HNE accumulation are linked to patient prognosis.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the effect of inhibiting GPX4 and FSP1 together in vitro?",{"text":72,"@type":64},"Combined inhibition of GPX4 and FSP1 synergistically induced cell death in vitro. The observed death is non-apoptotic.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340078,1790099385,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Article  \nLipid Peroxidation Regulators GPX4 and FSP1 as Prognostic Markers and Therapeutic Targets in Advanced Gastric Cancer  \nKazuhiro Tamura 1, Yoshinobu Tomita 1, Takumi Kanazawa 1,2, Hajime Shinohara 3, Masayoshi Sakano 3, Sachiko Ishibashi 4, Masumi Ikeda 4, Mayumi Kinoshita 1,2, Junko Minami 1, Kurara Yamamoto 1, Yuki Kato 1, Asuka Furukawa 1, Shigeo Haruki 3, Masanori Tokunaga 3, Yusuke Kinugasa 3, Morito Kurata 4, Masanobu Kitagawa 4, Kenichi Ohashi 1 and Kouhei Yamamoto 1,4, *  \nCitation: Tamura, K.; Tomita, Y.; Kanazawa, T.; Shinohara, H.; Sakano, M.; Ishibashi, S.; Ikeda, M.; Kinoshita, M.; Minami, J.; Yamamoto, K.; et al. Lipid Peroxidation Regulators GPX4 and FSP1 as Prognostic Markers and Therapeutic Targets in Advanced Gastric Cancer. Int. J. Mol. Sci. 2024, 25, 9203. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms25179203  \nAcademic Editor: Marlena Brzozowa-Zasada  \nReceived: 31 July 2024  \nRevised: 20 August 2024  \nAccepted: 22 August 2024  \nPublished: 24 August 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Human Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan; [k.tamura.pth1@tmd.ac.jp](k.tamura.pth1@tmd.ac.jp) (K.T.); [18cm127@s.bgu.jp](18cm127@s.bgu.jp) (Y.T.); [23ms203@s.bgu.ac.jp](23ms203@s.bgu.ac.jp) (T.K.); [mkinoshita@bgu.ac.jp](mkinoshita@bgu.ac.jp) (M.K.); [jminami@toin.ac.jp](jminami@toin.ac.jp) (J.M.); [ykatpth1@tmd.ac.jp](ykatpth1@tmd.ac.jp) (Y.K.); [a.tajima.pth1@tmd.ac.jp](a.tajima.pth1@tmd.ac.jp) (A.F.); [kohashi.pth1@tmd.ac.jp](kohashi.pth1@tmd.ac.jp) (K.O.)  \n2 Department of Clinical Laboratory Medicine, Faculty of Health Science Technology, Bunkyo Gakuin University, Tokyo 113-8668, Japan  \n3 Department of Gastrointestinal Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan; [h.shino524@gmail.com](h.shino524@gmail.com) (H.S.);  \n[masakun04222@gmail.com](masakun04222@gmail.com) (M.S.); [harukishigeo@me.com](harukishigeo@me.com) (S.H.); [tokunaga.srg1@tmd.ac.jp](tokunaga.srg1@tmd.ac.jp) (M.T.);  \n[kinugasa.srg1@tmd.ac.jp](kinugasa.srg1@tmd.ac.jp) (Y.K.)  \n4 Department of Comprehensive Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan; [sishpth2@tmd.ac.jp](sishpth2@tmd.ac.jp) (S.I.); [mikepth2@tmd.ac.jp](mikepth2@tmd.ac.jp) (M.I.); [kurata.pth2@tmd.ac.jp](kurata.pth2@tmd.ac.jp) (M.K.); [kitagawa@nakanosogo.or.jp](kitagawa@nakanosogo.or.jp) (M.K.)  \n* [Correspondence: yamamoto.pth2@tmd.ac.jp](Correspondence: yamamoto.pth2@tmd.ac.jp)  \nAbstract: Gastric cancer is one of the most common cancers worldwide, and new therapeutic strategies are urgently needed. Ferroptosis is an intracellular iron-dependent cell death induced by the accumulation of lipid peroxidation, a mechanism different from conventional apoptosis and necrosis. Therefore, induction of ferroptosis is expected to be a new therapeutic strategy. Glutathione peroxidase 4 (GPX4) and ferroptosis suppressor protein 1 (FSP1) have been identified as the major inhibitors of ferroptosis. Herein, we performed immunohistochemistry for GPX4, FSP1, and 4-HNE using tissues from patients with gastric cancer and investigated the relationship between these factors and prognosis. Patients with high GPX4 expression or high GPX4 expression and low 4-HNE accumulation tended to have a poor prognosis (p = 0.036, 0.023), whereas those with low FSP1 expression and high 4-HNE accumulation had a good prognosis (p = 0.033) . The synergistic induction of cell death by inhibiting GPX4 and FSP1 in vi","cbCaihqemgUsPTOB","https://ap.wps.com/l/cbCaihqemgUsPTOB","pdf",3624220,15,"English","# Introduction\n## Clinical need in advanced gastric cancer\n## Ferroptosis and lipid peroxidation\n# Study rationale and approach\n## Immunohistochemistry biomarkers (GPX4, FSP1, 4-HNE)\n## In vitro inhibition and cell death phenotype\n# Key findings\n## Prognostic associations of biomarker expression\n## Synergistic non-apoptotic effects of GPX4 and FSP1 inhibition\n# Implications\n## Therapeutic targeting for poor-prognosis patients","[{\"question\":\"What biological process is emphasized as a new therapeutic strategy in advanced gastric cancer?\",\"answer\":\"The article emphasizes ferroptosis, an intracellular iron-dependent cell death caused by accumulation of lipid peroxidation. This process differs from apoptosis and necrosis.\"},{\"question\":\"Which biomarkers are evaluated to assess prognosis in gastric cancer patients?\",\"answer\":\"The study evaluates GPX4, FSP1, and 4-HNE in patient tissues using immunohistochemistry. Their expression levels and 4-HNE accumulation are linked to patient prognosis.\"},{\"question\":\"What is the effect of inhibiting GPX4 and FSP1 together in vitro?\",\"answer\":\"Combined inhibition of GPX4 and FSP1 synergistically induced cell death in vitro. The observed death is non-apoptotic.\"}]","Lipid Peroxidation Regulators GPX4 and FSP1 as Prognostic Markers and Therapeutic Targets in Advanced Gastric Cancer - Article Summary | PDF",1790034043,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/62f720c138fb37c6cee7645904c0bd5b.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0186efc2045fbd86dfb5651f345c4656.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc554bcb691b0860043311f5f902d5d7.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff8011b4c0c76cf45f22cca360cdfdb6.webp",980,1385]